Insider trade

Microvision (MVIS): Director exercised options on 22K shares

Jeffrey A Herbst, Director at Microvision, reported an option exercise of 22K shares.

22K
Shares
Traded
Mar 2, 2026
Filed
Mar 3, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 12, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On January 12, 2026, MicroVision, Inc. (the “Company”) received a notification letter from The Nasdaq Stock Market (“Nasdaq”) advising that, based upon the closing bid price for the last 30 consecutive business days, the Company no longer meets the continued listing requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5450(a)(1).”
  2. Jan 26, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
  3. Feb 3, 2026Company filing · Form 8-K · Acquisition or saleCompleted buying or selling a business or assets“On February 3, 2026, pursuant to the terms of the Asset Purchase Agreement, the Acquisition was consummated and closing of the Acquisition (the “Closing”) occurred.”
  4. Feb 23, 2026Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 3 more items)
  5. Mar 2, 2026Layoff notice · RedmondLayoff notice filed in WA: 49 employees

What came next

  1. Mar 4, 2026Company filing · Form 8-K · ResultsReported its results
  2. May 13, 2026Company filing · Form 8-K · ResultsReported its results
  3. Jun 12, 2026Company filing · Form 8-K · Material agreement, Listing noticeReceived a notice from its stock exchange, and signed an important agreement (and 1 more item)“On June 12, 2026, the Company submitted an application to transfer the listing of the Company’s Common Stock from The Nasdaq Global Market to The Nasdaq Capital Market.”
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Microvision

OQRO holds no insider, Congress, fund or contract record for Microvision dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MVIS page.

How this filing works

Explore the data

Common questions

Which Microvision (MVIS) insider traded, and how much?

Jeffrey A Herbst, Director at Microvision, reported an option exercise of 22K shares. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Mar 2, 2026. Filed: Mar 3, 2026. That is 1 day between the two dates.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

Does this mean MVIS stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Microvision

Everything OQRO holds on this company is on its MVIS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data